aflo™
by Aflo
www.afloanalytics.com
aflo™ automates correct inhaler technique for better respiratory outcomes. aflo™ is designed to automate inhalation technique for patients, providing real-time data analytics for self-management and decision support for clinicians.

The patient and clinician codesigned aflo™ platform is a Class I intelligent medical device that automates, quantifies and records the 5 key steps of correct inhalation technique for pressurised Metered Dose Inhalers (MDI). It is an award winning user co-designed mobile App with real-time automated technique feedback, local air quality updates and dose reminders.
Key benefits:
  • Improves inhaler technique. The platform uses a smart medical device, companion app, and analytics hub to automate inhaler technique training, helping patients use their inhalers correctly and consistently.
  • Enhances symptom control. Clinical investigations have shown that users achieved better symptom control after using the platform, which can improve day-to-day management of asthma and COPD
  • Enables remote monitoring for clinicians. The cloud-based analytics hub provides clinicians with data on inhaler use and patient engagement, allowing remote monitoring and more informed treatment decisions.
  • Reduces healthcare costs and resource use. Better inhaler technique and adherence can reduce reliever medication use, avoidable healthcare visits, and overall treatment costs.
  • Supports personalised disease management. Combines inhaler performance data with environmental information (such as air quality) and user insights to help patients identify triggers and better manage their condition.

Focus: Chronic Disease